ecancermedicalscience

Short Communication

Molecular characterisation of signalling pathways in cancer stem cells

2 Dec 2008
C Regenbrecht, Y Welte, A Jödicke, R Hugel, P Walden, M Jung, H Lehrach, J Adjaye

To avoid artefacts introduced by culturing cells for extended periods of time, it is crucial to use low-passage patient-derived tumour cells. The ability to enrich, isolate and assay sub-populations of cells that behave as cancer stem cells (CSCs) from these primary cell lines is essential before performing characterisations such as gene-expression profiling. We have isolated cells from glioblastomas which show characteristics of CSCs. Although glioblastomas contain only a relatively small amount of putative CSCs, these cells express many genes which seem to be worthy targets for future therapies.

Related Articles

Uchenna Simon Ezenkwa, Gabriel Olabiyi Ogun, Mbwas Isaac Mashor, Olufemi John Ogunbiyi
Subramaniam Ramanathan, Sneha Sisodiya, Omshree Shetty, Maya Prasad, Badira C Parambil, Sneha Shah, Mukta Ramadwar, Nehal Khanna, Siddhartha Laskar, Sajid Qureshi, Tushar Vora, Girish Chinnaswamy
Muibat Haruna, Adetola Olubunmi Daramola, Nicholas Awodele Awolola, Nahla Mustafa Badr, Adekunbiola Aina Fehintola Banjo, Abeer Shaaban
S Gandini, PF Ferrucci, H Johanson, B Bonanni, A Testori
Prasanth S Ariyannur, Reenu Anne Joy, Veena Menon, Roopa Rachel Paulose, Keechilat Pavithran, Damodaran M Vasudevan
Saira Saleem, Iffat Aleem, Aribah Atiq, Sahrish Tariq, Amna Babar, Muhammad Abu Bakar, Madiha Syed, Maheen Maruf, Mohammad Tariq Mahmood, Muhammad Zeshan, Muhammad Tahseen, Raza Hussain, Asif Loya, Chris Sutton